Large Pharma Increasing Investment in Emerging Countries
Yesterday morning, Sanofi-Aventis SA (SNY-NYSE) released its 2010 financial results. Among other news, the ...
Unilife to report 2Q FY 2011 financial results in the U.S. on Feb. 14
After market close today, Crystal Research published a business update on Unilife Corp. (UNIS-NASDAQ). Beyond ...
Updated business outlook available on Peregrine Pharmaceuticals
We at Crystal are looking forward to an exciting week as we begin releasing new research in our revamped ...
Out with the old and in with the new…
This morning, we at Crystal Research debuted a new Research Library webpage. The new page is designed to be ...
Both Sides of the Fence for 2011
We hope everyone had an enjoyable and safe December, with happy, relaxing holidays. As 2011 approaches, a ...
New Research Released on BELLUS Health Inc.
Today we issued an updated, 44-page Executive Informational Overview® (EIO®) on BELLUS Health Inc. (BLU-TSX). ...
Updated Executive Informational Overview Released on Authentidate Holding Corp.
After the close of business today, we released a new report on Authentidate Holding Corp. (ADAT-NASDAQ). We ...
Unilife Reports Financial Results and Significant Milestones
Unilife Corp. (UNIS-NASDAQ) has recently announced its financial results for the three months ended September ...
Up to $1 Billion in New Credits/Grants for Healthcare
As part of the Patient Protection and Affordable Care Act of 2010, Congress established a program known as ...
New research available on Applied DNA Sciences
After the close of the market today, we published an updated Executive Informational Overview on Applied DNA ...
Bioniche Named Among Top Employers in Canada
Today, Bioniche Life Sciences Inc. (BNC-TSX), a research-based, technology-driven Canadian biopharmaceutical ...
New research available at crystalra.com
This morning, we at Crystal Research published a new Executive Informational Overview (go here to find out ...
Promising Clinical Events from Neuralstem and Peregrine
Neuralstem, Inc. (CUR-NYSE Amex) announced on Monday of this week that it would begin enrolling the next ...
Corporate Update from TapImmune and Positive Phase II Data from ACT Biotech
TapImmune Inc. (TPIV-OTC.BB), a developer of immunotherapeutics for cancer and infectious disease, yesterday ...
CEL-SCI’s progress toward the start of its Phase III trial
CEL-SCI Corporation (CVM-NYSE Amex) is advancing its Phase III clinical trial of Multikine®, CEL-SCI’s lead ...